"Randomized phase II study of azacitidine ± lenalidomide in higher-risk myelodysplastic syndromes and acute myeloid leukemia with a karyotype including Del(5q)".
作者信息
Rasmussen Bengt, Göhring Gudrun, Bernard Elsa, Nilsson Lars, Tobiasson Magnus, Jädersten Martin, Garelius Hege, Dybedal Ingunn, Grønbaek Kirsten, Ejerblad Elisabeth, Lorenz Fryderyk, Flogegård Max, Marcher Claus Werenberg, Öster Fernström Annette, Cavelier Lucia, Papaemmanuil Elli, Ebeling Freja, Kittang Astrid Olsnes, Nørgaard Jan Maxwell, Saft Leonie, Möllgård Lars, Hellström-Lindberg Eva
机构信息
School of Medical Sciences, Örebro University, Örebro, Sweden.
Department of Human Genetics, Hannover Medical School, Hannover, Germany.
出版信息
Leukemia. 2022 May;36(5):1436-1439. doi: 10.1038/s41375-022-01537-w. Epub 2022 Mar 11.
Abstract
摘要
Zotero 插件